Molecular test algorithms for digestive tumours
(2019) Belgian Journal of Medical Oncology — Vol. 13, n° 1, p. 4-10 (2019)
Files
2019_Hébrant_BJMO.pdf
Open Access - Adobe PDF
- 2.78 MB
Details
- Authors
- Abstract
- The Belgian Commission of Personalized Medicine has been created to advise the federal government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests. Here, we propose the Belgian strategy for molecular testing in the digestive tumours within a scientific-based framework. For each tested biomarker, a clinical test level is attached, which is key to establish the relevance of the test and to define the reimbursement. For each digestive tumour type, the different molecular tests are represented as decision trees with its test utility, test level and a brief technical test description
- Affiliations
Citations
Hébrant, A., Mourin, A., Froyen, G., Van der Meulen, J., de Man, M., Salgado, R., Van den Eynde, M., D’haene, N., Martens, G., Van Cutsem, E., Antoine-Poirel, H., Tejpar, S., Van Laethem, J.-L., Geboes, K., Pauwels, P., Dedeurwaerdere, F., Maes, B., De Greve, J., Vanhuysse, J., et al. (2019). Molecular test algorithms for digestive tumours. Belgian Journal of Medical Oncology, 13(1), 4-10. https://hdl.handle.net/2078.5/53094 (Original work published 2019)